Capricor Therapeutics(GB:0HTB)
GB:0HTB
Capricor Therapeutics ownership
Capricor Therapeutics (0HTB) Ownership - Who Owns Capricor Therapeutics?
0 Followers
Capricor Therapeutics (0HTB) Ownership Overview
- 0.93% Insiders
- 7.61% Mutual Funds
- 0.62% Other Institutional Investors
- 12.24% ETFs
- 78.60% Public Companies and Individual Investors
The ownership structure of Capricor Therapeutics (GB:0HTB) stock is a mix of institutional, retail, and individual investors. Approximately 20.47% of the company’s stock is owned by Institutional Investors, 0.93% is owned by Insiders, and 78.60% is owned by Public Companies and Individual Investors.
The ownership structure of Capricor Therapeutics (GB:0HTB) stock is a mix of institutional, retail, and individual investors. Approximately 20.47% of the company’s stock is owned by Institutional Investors, 0.93% is owned by Insiders, and 78.60% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Goalvest Advisory Llc | €59,163 | |
| Dec 31, 2025 | Woodline Partners Lp | €6,322,821 | |
| Dec 31, 2025 | Ra Capital Management | €43,516,377 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 4,145,061 | Institution | 7.13% | ― |
| Vanguard | 2,769,947 | Institution | 4.76% | ― |
| Vanguard Index Funds | 2,246,873 | Institution | 3.86% | ― |
| Ishares | 2,077,862 | Institution | 3.57% | ― |
| Spdr | 2,047,867 | Institution | 3.52% | ― |
| Peter Kolchinsky | 1,507,844 | Institution | 2.59% | ― |
| Fidelity Salem Street Trust | 646,025 | Institution | 1.11% | ― |
| Vanguard Scottsdale Funds | 371,326 | Institution | 0.64% | ― |
| Fidelity Concord Street Trust | 347,831 | Institution | 0.60% | ― |
| Linda Marban | 211,104 | Insider | 0.36% | ― |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 2,246,873 | Institution | 3.86% | ― |
| Fidelity Salem Street Trust | 646,025 | Institution | 1.11% | ― |
| Vanguard Scottsdale Funds | 371,326 | Institution | 0.64% | ― |
| Fidelity Concord Street Trust | 347,831 | Institution | 0.60% | ― |
| Tiaa-cref Funds | 177,039 | Institution | 0.30% | ― |
| Schwab Capital Trust | 160,898 | Institution | 0.28% | ― |
| Vanguard World Fund | 140,884 | Institution | 0.24% | ― |
| Jpmorgan Trust I | 48,562 | Institution | 0.08% | ― |
| Vanguard Explorer Fund | 40,091 | Institution | 0.07% | ― |
| Vanguard Valley Forge Funds | 25,820 | Institution | 0.04% | ― |
FAQ
Who Owns Capricor Therapeutics (GB:0HTB)?
According to the latest TipRanks data, approximately 20.47% of the company's stock is held by institutional investors, 0.93% is held by insiders, and 78.60% is held by public companies and individual investors.
What percentage of Capricor Therapeutics (GB:0HTB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 20.47% of Capricor Therapeutics (GB:0HTB) stock is held by institutional investors: 7.61% by mutual funds, 12.24% by ETFs and 0.62% by other institutional investors.
What percentage of Capricor Therapeutics (GB:0HTB) stock is held by retail investors?
According to the latest TipRanks data, approximately 78.60% of Capricor Therapeutics (GB:0HTB) stock is held by public companies and individual investors.
Who owns the most shares of Capricor Therapeutics (GB:0HTB)?
BlackRock, Inc. owns the most shares of Capricor Therapeutics (GB:0HTB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
